No evidence of an association of multiple sclerosis (MS) with Borna disease virus 1 (BoDV-1) infections in patients within an endemic region: a retrospective pilot study

被引:1
|
作者
Bauswein, Markus [1 ]
Knoll, Gertrud [1 ]
Schmidt, Barbara [1 ]
Gessner, Andre [1 ]
Hemmer, Bernhard [2 ,3 ]
Flaskamp, Martina [2 ]
机构
[1] Univ Hosp Regensburg, Inst Clin Microbiol & Hyg, Regensburg, Germany
[2] Tech Univ Munich, Sch Med, Dept Neurol, Klinikum Rechts Isar, Munich, Germany
[3] Munich Cluster Syst Neurol SyNergy, Munich, Germany
关键词
Borna disease virus (BoDV-1); Encephalitis; Multiple sclerosis (MS); ELISA; iIFA; Serology; ENCEPHALITIS; GERMANY;
D O I
10.1007/s15010-023-02099-4
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
BackgroundBorna disease virus 1 (BoDV-1) causes rare human infections within endemic regions in southern and eastern Germany. The infections reported to date have been linked to severe courses of encephalitis with high mortality and mostly irreversible symptoms. Whether BoDV-1 could act as a trigger for other neurological conditions, is, however, incompletely understood.Objectives and methodsIn this study, we addressed the question of whether the presentation of a clinically isolated syndrome (CIS) or of multiple sclerosis (MS) might be associated with a milder course of BoDV-1 infections. Serum samples of 100 patients with CIS or MS diagnosed at a tertiary neurological care center within an endemic region in southern Germany and of 50 control patients suffering from headache were retrospectively tested for BoDV-1 infections.ResultsIn none of the tested sera, confirmed positive results of anti-BoDV-1-IgG antibodies were retrieved. Our results support the conclusion that human BoDV-1 infections primarily lead to severe encephalitis with high mortality.
引用
收藏
页码:243 / 247
页数:5
相关论文
共 29 条
  • [21] Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial
    Mikol, Daniel D.
    Barkhof, Frederik
    Chang, Peter
    Coyle, Patricia K.
    Jeffery, Douglas R.
    Schwid, Steven R.
    Stubinski, Bettina
    Uitdehaag, Bernard M. J.
    Ballario, C.H.
    Caceres, FJ
    Correale, J
    Cristiano, E
    Garcea, DO
    Leutic, GG
    Aicher, F
    Barreira, AA
    Freedman, M
    Grand'Maison, F
    Jacques, F
    Lee, L
    Stefanelli, M
    Edan, G
    Pelletier, J
    Berghoff, M
    Keifer, R
    Koehler, J
    Hardiman, O
    Comi, G
    Mancardi, GL
    Pozzilli, C
    Trojano, MP
    Barkhof, F
    Jongen, P
    Uitdehaag, BM
    Belova, AN
    Boyko, AN
    Elchaninov, AP
    Kozlov, VA
    Odinak, MM
    Shvarkov, SB
    Skoromets, AA
    Spirin, NN
    Stolyarov, ID
    Vorobieva, OV
    Zavalishin, I
    Arbizu, T
    Fernandez, O
    Izquierdo, G
    Montalban, X
    Goebels, N
    LANCET NEUROLOGY, 2008, 7 (10): : 903 - 914
  • [22] Predictive value of early MRI measures for long-term disease activity in patients with relapsing-remitting multiple sclerosis receiving IFN β-1a SC tiw or IFN β-1a IM qw: post hoc analyses of the EVIDENCE study
    Coyle, P. K.
    Freedman, M. S.
    Dangond, F.
    Fang, J.
    Reder, A. T.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 594 - 595
  • [23] Predictive Value of Early MRI Measures for Long-Term Disease Activity in Patients with Relapsing-Remitting Multiple Sclerosis Receiving IFN β-1a SC tiw or IFN β-1a IM qw: Post Hoc Analyses of the EVIDENCE Study
    Coyle, Patricia
    Freedman, Mark
    Dangond, Fernando
    Fang, Juanzhi
    Reder, Anthony
    NEUROLOGY, 2016, 86
  • [24] Effects of serial macrocyclic-based contrast materials gadoterate meglumine and gadobutrol administrations on gadolinium-related dentate nuclei signal increases in unenhanced T1-weighted brain: a retrospective study in 158 multiple sclerosis (MS) patients
    Alessandra Splendiani
    Marco Perri
    Claudia Marsecano
    Valentina Vellucci
    Giulia Michelini
    Antonio Barile
    Ernesto Di Cesare
    La radiologia medica, 2018, 123 : 125 - 134
  • [25] Effects of serial macrocyclic-based contrast materials gadoterate meglumine and gadobutrol administrations on gadolinium-related dentate nuclei signal increases in unenhanced T1-weighted brain: a retrospective study in 158 multiple sclerosis (MS) patients
    Splendiani, Alessandra
    Perri, Marco
    Marsecano, Claudia
    Vellucci, Valentina
    Michelini, Giulia
    Barile, Antonio
    Di Cesare, Ernesto
    RADIOLOGIA MEDICA, 2018, 123 (02): : 125 - 134
  • [26] Re: Effects of serial macrocyclic-based contrast materials gadoterate meglumine and gadobutrol administrations on gadolinium-related dentate nuclei signal increases in unenhanced T1-weighted brain: a retrospective study in 158 multiple sclerosis (MS) patients
    Jean-Sébastien Raynaud
    Elisabeth Darmon-Kern
    Eric Lancelot
    Anne-Coline Laurent
    Pierre Desché
    La radiologia medica, 2018, 123 : 432 - 433
  • [27] Re: Effects of serial macrocyclic-based contrast materials gadoterate meglumine and gadobutrol administrations on gadolinium-related dentate nuclei signal increases in unenhanced T1-weighted brain: a retrospective study in 158 multiple sclerosis (MS) patients
    Raynaud, Jean-Sebastien
    Darmon-Kern, Elisabeth
    Lancelot, Eric
    Laurent, Anne-Coline
    Desche, Pierre
    RADIOLOGIA MEDICA, 2018, 123 (06): : 432 - 433
  • [28] Reply to: RE: effects of serial macrocyclic-based contrast materials gadoterate meglumine and gadobutrol administrations on gadolinium-related dentate nuclei signal increases in unenhanced T1-weighted brain—a retrospective study in 158 multiple sclerosis (MS) patients
    Alessandra Splendiani
    La radiologia medica, 2018, 123 : 535 - 537
  • [29] Reply to: RE: effects of serial macrocyclic-based contrast materials gadoterate meglumine and gadobutrol administrations on gadolinium-related dentate nuclei signal increases in unenhanced T1-weighted brain-a retrospective study in 158 multiple sclerosis (MS) patients
    Splendiani, Alessandra
    RADIOLOGIA MEDICA, 2018, 123 (07): : 535 - 537